Chemotherapy's hidden toll on blood vessels revealed
NCT ID NCT03062878
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looked at how anthracycline-based chemotherapy affects blood vessel health and blood pressure control in 60 people with breast cancer or lymphoma. Researchers measured artery stiffness, blood flow, and skin blood vessel responses. The goal is to understand why cancer survivors face higher heart disease risk and find ways to reduce it.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors understand how chemotherapy harms blood vessels, leading to better ways to protect heart health in cancer survivors.
- What could go wrong
- This is an observational study, not a treatment trial. It only measures changes and does not test any new therapy, so it cannot directly improve patient outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Lafene Health Center
Manhattan, Kansas, 66502, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a personalized exercise program boost recovery in cancer survivors?
- Could muscle loss predict blood cancer outcomes?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?
- Can we predict chemo brain before it happens?